Business
OWC Pharmaceutical Research Advisory Board Member to Participate in the First Bloomberg Intelligence Sponsored Cannabis Event
OWC Pharmaceutical Research Advisory Board Member to Participate in the First Bloomberg Intelligence Sponsored Cannabis Event.
About this update from Owc Pharmaceutical Research Corp
[{"type":"text","content":"\n\n\n\nOWC Pharmaceutical Research Advisory Board Member to Participate in the First Bloomberg Intelligence Sponsored Cannabis Event\n\n\n\n\n\nOWC Pharmaceutical Research Advisory Board Member to Participate in the First Bloomberg Intelligence Sponsored Cannabis Event\nBloomberg's \"Cannabis Trends & Legalization Implications\" Will be Held Monday, November 21st in New York\nPR Newswire\nPETACH TIKVA, Israel, November 18, 2016\n\n\n\nPETACH TIKVA, Israel, November 18, 2016 /PRNewswire/ --\n\nPETACH TIKVA, Israel, November 18, 2016: OWC Pharmaceutical Research Corp. (OTCQB: OWCP), (\"OWC\" or the \"Company\"), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced that Jeffrey Friedland, a member of the Company's Advisory Board, will be participating in Bloomberg Intelligence's first cannabis-related event; Cannabis Trends & Legalization Implications.\n\n     (Logo: http://photos.prnewswire.com/prnh/20150311/734965-a )\n\n\n     (Logo: http://photos.prnewswire.com/prnh/20150311/734965-b )\n\n\nCannabis Trends & Legalization Implications will be held Monday, November 21st in New York City, and will explore the most important legal, medical and financial developments and issues associated with America's marijuana industry. The session will start with a panel of key players in the space, dissecting the implications and opportunities associated with cannabis decriminalization across the United States. It will be moderated by Kenneth Shea, Senior Consumer Products Analyst of Bloomberg Intelligence.\n\nIt is anticipated that Mr. Friedland, who is also the author of Marijuana: The World's Most Misunderstood Plant, will have the opportunity to highlight to event attendees the progress that OWC has made with its medical cannabis research in Israel, and the positive impact that OWC and other Israeli companies are having on state-licensed U.S. growers and extractors.\n\nWhen asked about his participation in the Bloomberg event, Mr. Friedland stated, \"I've been involved in the legal cannabis industry for several years now; including as the CEO of INTIVA Inc., an investor and operator of businesses in the global cannabis market. I view the cannabis industry as an emerging global market with several sectors, including m...